BML-210, CAS [[537034-17-6]]

Produktübersicht

• Artikelname: BML-210, CAS [[537034-17-6]]
• Artikelnummer: MCE-HY-19350
• Hersteller Artikelnummer: HY-19350
• Alternativnummer: MCE-HY-19350-10MMX1ML,MCE-HY-19350-25MG,MCE-HY-19350-5MG,MCE-HY-19350-50MG,MCE-HY-19350-10MG,MCE-HY-19350-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

BML-210 is a potent HDAC inhibitor. BML-210 can inhibit the HDAC4-VP16-driven reporter signal with an apparent IC50 of 5 µM. BML-210 has a specific disruptive effect on the HDAC4:MEF2 interaction. BML-210 causes an increase in the G0/G1 phase. BML-210 induces apoptosis and displays antitumour activities in orthotopic mammary tumours in mice[1][2][3].

Produkteigenschaften

• Molekulargewicht: 339.43
• Reinheit: 98.04
• CAS Nummer: [537034-17-6]
• Formel: C20H25N3O2
• Target-Kategorie: Apoptosis,HDAC

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound1